title: [Advances in biologic therapy for inflammatory bowel disease].
abstract: The medical management of inflammatory bowel disease has considerably changed thanks to the biologic agents coming. In this review a critical evaluation of controlled studies with biologic agents for the management of both Crohn's disease and ulcerative colitis is presented. The efficacy of these agents in moderate to severe ulcerative colitis and Crohn's disease has been one of the most important advances in the past decades.
authors.affiliation: Unità Operativa Autonoma Gastroenterologia, Azienda Ospedaliera Ordine Mauriziano, Torino.
authors.forename: Raffaello
authors.initials: R
authors.lastname: Sostegni
authors.forename: Angelo
authors.initials: A
authors.lastname: Pera
authors.forename: Marco
authors.initials: M
authors.lastname: Daperno
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Rocca
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001691:Biological Therapy; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal